38 results
POS AM
ADIL
Adial Pharmaceuticals Inc
24 Jun 22
Prospectus update (post-effective amendment)
5:11pm
may result in unexpected costs, or to discontinue the clinical trials altogether;
delays in necessary interactions with local regulators, ethics … with the Company’s Code of Business Conduct and Ethics, investigating alleged breaches or violations thereof and enforcing its provisions.
Special Committee
During
POS AM
yp7 ogcdk
24 Jun 22
Prospectus update (post-effective amendment)
5:02pm
POS AM
k70zbq3
6 Apr 21
Prospectus update (post-effective amendment)
12:00am
POS AM
wf5fpm40f3qytlqm5r
6 Apr 21
Prospectus update (post-effective amendment)
12:00am
424B3
a842dne8b
13 Jul 20
Prospectus supplement
4:46pm
8-K
EX-99.1
stwah79iaaa0zwae
11 Jun 20
Adial Pharmaceuticals Announces Approval to Commence Landmark ONWARD™ Pivotal Phase 3 Trial in Poland
11:58am
424B5
emwzjtfy4txd7g3c8gg7
10 Jun 20
Prospectus supplement for primary offering
4:14pm
424B3
wnzpebzy
22 May 20
Prospectus supplement
4:30pm
424B3
2adno
22 May 20
Prospectus supplement
4:28pm